SZSE Ticker: 300482

Guangzhou Wondfo Biotech Co., Ltd

广州万孚生物技术股份有限公司

万孚生物

WONDFO BIOTECH

Listing Date: 2015-06-30

Board: GEM

Industry Classification: Manufacturing

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

The first case after the implementation of the new "Securities Law"! WuXi PharmaTech's shareholders were fined 200 million for illegally reducing their holdings

Post date May 14, 2022 — 18:40 Post Lock

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value

Post date May 14, 2022 — 13:05 Post Lock

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net

Post date May 14, 2022 — 11:00 Post Lock

The price of centralized procurement has fallen below 4 yuan: is the new crown antigen detection reagent still a good track? Jiu'an Medical_Sina Finance_Sina.com

Post date May 13, 2022 — 21:46 Post Lock

Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline

Post date May 13, 2022 — 21:04 Post Lock

Real estate and auto stocks led the A-share market to close up, turnover further shrunk to 757.1 billion

Post date May 13, 2022 — 17:29 Post Lock

Real estate and auto stocks led the A-share market to close up, with turnover further shrinking to 757.1 billion

Post date May 13, 2022 — 17:26 Post Lock

Central Bureau Observation of Nucleic Acid Testing①｜The demand for new crown testing has changed from strong to weak, and the changes in the IVD industry and the new situation 21 Economic Net

Post date May 12, 2022 — 13:32 Post Lock

3.2 billion main capital withdrew from hepatitis concept stocks in the past three days jqknews

Post date May 11, 2022 — 20:54 Post Lock

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

Post date May 10, 2022 — 10:07 Post Lock

[Transaction stock] The hepatitis concept sector fell, and Shuangcheng Pharmaceutical (002693.CN) fell 6.63%-Hong Kong Stocks-Financial

Post date May 9, 2022 — 12:30 Post Lock

The unit price of nucleic acids and antigens is as low as less than 4 yuan. Where is the way out for companies that rely on new crown detection to make money?

Post date May 7, 2022 — 22:56 Post Lock

The unit price of nucleic acid and antigen is as low as less than 4 yuan. Where is the way out for companies that rely on new crown detection to make money? Antigen nucleic acid amplification reagents?

Post date May 7, 2022 — 22:56 Post Lock

The unit price of nucleic acid and antigen is as low as less than 4 yuan. Where is the way out for companies that rely on new crown detection to make money?

Post date May 7, 2022 — 22:56 Post Lock

The unit price of nucleic acids and antigens is as low as less than 4 yuan. Where is the way out for companies that rely on new crown testing to make money?

Post date May 7, 2022 — 22:23 Post Lock

The unit price of nucleic acids and antigens is as low as less than 4 yuan. Where is the way out for companies that rely on new crown testing to make money?

Post date May 7, 2022 — 20:59 Post Lock

The unit price of nucleic acids and antigens is as low as less than 4 yuan. Where is the way out for companies that rely on new crown detection to make money?

Post date May 7, 2022 — 20:55 Post Lock

The unit price of nucleic acids and antigens is as low as less than 4 yuan. Where is the way out for companies that rely on new crown detection to make money?

Post date May 7, 2022 — 19:36 Post Lock

The unit price of nucleic acid and antigen is as low as less than 4 yuan, where is the way out for companies that rely on new crown detection to make money?

Post date May 7, 2022 — 19:35 Post Lock

Want to see more data? Registered subscribers can see all the data.